Quality of life and Parkinson's disease;Calidad de vida y enfermedad de Parkinson

Neurologia

Volumn 14, Issue 4, 1999, Pages 164-171

  Martinez Martin P ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH SURVEY; HUMAN; PARKINSON DISEASE; QUALITY OF LIFE; REVIEW; SPAIN;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; QUALITY OF LIFE;

EID: 2442763188     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. a ed.). Ginebra: WHO, Palais des Nations 1952; 3-20.
2. Esteve M, Roca J. Calidad de vida relacionada con la salud: un nuevo parámetro a tener en cuenta. Med Clin (Bare) 1997; 108: 458-459.
3. a ed.). Filadelfia: Lippincot-Raven Publishers, 1996; 11-23.
4. a ed.). Filadelfia: Lippincot-Raven Publishers, 1996; 1-10.
5. Editorial. Quality of life and clinical trials. Lancet 1995; 346: 1-2.
6. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996; 334: 835-840.
7. Fallowfield L. Quality of quality-of-life data. Lancet 1996; 348: 421.
8. Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of life measures in health care. I. Applications and issues in assessment. BMJ 1992; 305: 1.074-1.077.
9. Patrick DL, Erickson P. Health status and health policy. Quality of life in health care evaluation and resource allocation. Nueva York, Oxford: Oxford University Press, 1993; 113-142.
10. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-629.
11. Bergner M, Bobbitt RA, Pollard WE, Martin DP, Gilson BS. The Sickness Impact Profile: validation of a health status measure. Med Care 1976; 14: 57-67.
12. Hunt SM, McEwen J, McKenna SP. Measuring Health Status. Londres: Croom Helm, 1986.
13. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
14. Kaplan RM, Anderson JP, Ganiats TG. The Quality of Well-Being Scale: rationale for a single quality of life index. En: Walker SR, Rosser RM, editores. Quality of life assessment: key issues in the 1990s. Dordrecht: Kluwer Academic Publishers, 1993; 65-94.
15. Mitchell A, Guyatt G, Singer J, Irvine EJ, Goodacre R, Tompkins C et al. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol 1988; 10: 306-310.
16. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147: 832-838.
17. a ed.). Filadelfia: Lippincott-Raven Publishers, 1996; 49-56.
18. De Boer AGEM, Wijker W, Speelman JD, de Haes JCJM. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996; 61: 70-74.
19. Badía X, Salamero M, Alonso J, Ollé A. La medida de la salud. Guía de escalas de medición en español. Barcelona: Promociones y Publicaciones Universitarias, S.A., 1996.
20. Fitzsimmons B, Bunting LK. Parkinson's disease. Quality of life issues. Nursing Clin N Am 1993; 28: 807-818.
21. Shindler JS, Brown R, Welburn P, Parkes JD. Measuring the quality of life of patients with Parkinson's disease. En: Walker SR, Rosser RM, editores. Quality of life assessment: key issues in the 1990s. Dordrecht: Kluwer Academic Publishers, 1993; 289-300.
22. Fukunaga H, Kasai T, Yoshidome H. Clinical findings, status of care, comprehensive quality of life, daily life therapy and treatment at home in patients with Parkinson's disease. Eur Neurol 1997; 38 (Supl 2): 64-69.
23. Wilson RS, Goetz CG. Neurologic illness. En: Spilker B, editor. Quality of life assessment in clinical trials. Nueva York: Raven Press Ltd., 1990; 347-356.
24. McRae C, O'Brien C, Freed C. Quality of life among persons receiving neural implant surgery for Parkinson's disease. Mov Disord 1996; 11: 605-606.
25. Baron MS, Vitek JL, Bakay RAE, Green J, Kaneoke Y, Hashimoto T et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996; 40: 355-366.
26. Block G, Liss C, Reines S, Irr J, Nibbelink D, The CR First Study Group. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicentric 5-year study. Eur Neurol 1997; 37: 23-27.
27. Pahwa R, Lyons K, McGuire D, Silverstein P, Zwiebel T, Robischon M et al. Comparison of standard carbidopalevodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and Quality-of-life measures. Mov Disorders 1997; 12: 677-681.
28. Grandas F, Martínez-Martín P, Linazasoro G, The STAR Multicenter Study Group. Quality of life in patients with Parkinson's disease who transferred from standard levodopa to Sinemet CR. The STAR Study. J Neurology 1998; 245 (Supl 1): 31-33.
29. Sêdek G, Jorga K, Schmitt M, Burns RS, Leese P. Effect of tolcapone on plasma levodopa concentrations after coadministration with levodopa/carbidopa to healthy volunteers. Cin Neuropharmacol 1997; 20: 531-541.
30. Roberts JW, Cora-Locatelli G, Bravi D, Amantea MA, Mouradian MM, Chase TN. Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients. Neurology 1994; 44: 2.685-2.688.
31. Rajput AH, Martin W, Saint-Hilaire M-H, Dorflinger E, Pedder S. Tolcapone improves motor function in parkinsonian patients with the "wearing-off" phenomenon: a double-blind, placebo-controlled, multicenter trial. Neurology 1997; 49: 1.066-1.071.
32. Baas H, Beiske AG, Ghika J, Jackson M, Oertel WH, Poewe W et al. Cathecol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requierements in fluctuating parkinsonian patients. J Neurol Neurosurg Psychiatry 1997; 63: 421-428.
33. Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N. Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the Short-form Health Survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39). Age Ageing 1995; 24: 505-509.
34. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995; 4: 241-248.
35. Martínez-Martín P, Frades Payo B, Fontán Tirado C, Martínez-Sarriés FJ, Guerrero MT, del Ser Quijano T. Valoración de la calidad de vida en Ia enfermedad de Parkinson mediante el PDQ-39. Estudio piloto. Neurología 1997; 12: 56-60.
36. Martínez-Martín P, Frades Payo B, The "Grupo Centro" for Study of Movement Disorders. Quality of life and clinical assessment in Parkinson's disease. Validation study of the P,DQ-39 Spanish version. J Neurology 1998; 245 (Supl 1): 34-38.
37. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997; 26: 353-357.
38. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The PDQ-8: development and validation of a short-form Parkinson's disease questionnaire. Psychology Health 1997; 12: 805-814.
39. Scott R, Gregory R, Hines N, Carroll C, Hyman N, Papanasstasiou V et al. Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures. Brain 1998; 121: 659-675.
40. Martínez-Martín P, Valldeoriola F, Nobbe F, Molinuevo JL, Rumiá J, Tolosa E. Quality of life and clinical changes after stereotactic pallidotomy (sP) in Parkinson's disease (PD). Mov Disord 1998; 13 (Supl 2): 63.
41. Martínez-Martín P, del Ser T, Aguilar M, Peto V, The QoL Study Group. Controlled-release levodopa-carbidopa (CRLC) treatment and quality of life (QoL) of Parkinson's disease (PD) patients as measured by the PDQ-39. Eur J Neurol 1998; 5 (Supl 3): 171.
42. Calne S, Schulzer M, Mak E, Guyette C, Rohs G, Hatchard S et al. Validating a quality of life rating scale for idiopathic Parkinsonism: Parkinson's Impact Scale (PIMS). Parkinsonism Relat Disord 1996; 2: 55-61.
43. Whetten-Goldstein K, Sloan F, Kulas E, Cutson T, Schenkman M. The burden of Parkinson's disease on society, family, and the individual. J Am Geriatr Soc 1997; 45: 844-849.
44. Carter JH, Stewart BJ, Archbold PG, Inove I, Jaglin J, Lannan M et al. Living with a person who has Parkinson's disease: the spouse's perspective by stage of disease. Mov Disord 1998; 13: 20-28.
45. Wallhagen MI, Brod M. Perceived control and well-being in Parkinson's disease. West J Nurs Res 1997; 19: 11-25.
46. Glozman JM, Bitcheva KG, Fedorova NV. Parkinson's disease and quality of life of caregivers. Mov Disord 1997; 12 (Supl 1): 48.